Still unclear what happens when a treatment arm patient 'crosses over'. Do they 'reset the clock' or just continue dosing regimen? (I'm unclear). Do they employ placebo at all after crossover? I doubt it, but some have suggested they would. Must be in the protocol somewhere, or the site investigators would be confused...